SSTR PET finds more distant disease in GEP-NETs
In this 24-year surgical cohort, SSTR PET identified bone and retroperitoneal nodal metastases more often than Octreoscan—findings that may matter for operative planning.
Newsletter
Sarcoma & rare tumors
Every new paper in this field, in your inbox.
Mapping Surgical Evidence for GEP-NETs
Surgical management of gastro-entero-pancreatic neuroendocrine tumors is inconsistent, highlighting the need for clearer guidelines.
Gallium-68 PET for Pancreatic Neuroendocrine Tumors: Limited Sensitivity
A study shows Gallium-68 DOTATATE PET has high specificity but low sensitivity in identifying lymph node metastases in pancreatic neuroendocrine tumors, affecting surgical decisions.
Salvage Treatment After Incomplete Rectal NET Resection Shows Promise
Salvage treatment may be warranted after incomplete resection of rectal neuroendocrine tumors due to significant residual disease concerns.
New Immune Signatures in MEN1-Related Tumors
Identifying immune signatures could refine patient selection and surgical outcomes for those with MEN1-related neuroendocrine tumors.
Surgery improves outcomes for gastroenteropancreatic neuroendocrine tumors with liver metastasis.
Surgeons should prioritize surgical intervention for eligible patients, as it significantly enhances survival.
Predicting Recurrence in Lymph Node-Negative Pancreatic Tumors
A new risk score for lymph node-negative pancreatic neuroendocrine tumors helps identify patients at risk for recurrence and guides postoperative surveillance.
Outcomes for Retroperitoneal Sarcoma Patients Improve Significantly
Recent management of primary retroperitoneal sarcomas shows improved survival rates over time.
Surgery First Improves Outcomes in Primary Intestinal Lymphoma
Surgery first significantly enhances survival and safety in primary intestinal lymphoma compared to chemotherapy first.
Perineural invasion worsens survival in resected pancreatic tumors
Patients with pancreatic neuroendocrine tumors (PNETs) and perineural invasion (PNI) face significantly worse outcomes post-surgery.